Interestingly, TP53 represses FOXM1 following DNA damage [58] suggesting that the high rate of TP53 mutation in high-grade serous ovarian cancer contributes to FOXM1 over-expression. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.